Partnership Across the Pond: EMA, FDA Foster a Culture of Convergence

GW Readies Cannabis-based Drug for EU Market

Notes from BIO 2009: Up to $400,000/Day to Support an Inspection, Genentech Says

A Contrarian View of FDA: Bloated and Inefficient

BIO 2008: What? FDA STILL hasn’t been accepted into The Pharmaceutical Inspectorate?